Literature DB >> 23389725

Rhinocerebral mucormycosis: literature review apropos of a rare entity.

Carla Alexandra Teixeira1, Pedro Bettencourt Medeiros, Pedro Leushner, Fernanda Almeida.   

Abstract

Mucormycosis is a rare fungal infection that affects immunocompromised patients, and the rhinoorbitocerebral presentation is the most common clinical form of the disease, often associated with diabetes mellitusThe treatment is complex and involves amphotericin B and surgery. Studies show increasing success without or with minimal surgeries. The authors present the case of a diabetic woman with a 1-month history of intranasal and right periorbital pain associated with progressive deficit of various cranial nerves, sudden amaurosis and homolateral ptosis. Rhizopus oryzae species was identified in pus in the nasal mucosa. She was treated with antifungal therapy and minimal surgical debridement with success. The authors decided on publication because of the rarity of this entity, alerting for the need of a high suspicion index for the diagnosis, which should be made as early as possible due to the high mortality rate, as well as presenting data about the increasing discussion of therapeutic strategies, with some new approaches that prioritise minimal surgeries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389725      PMCID: PMC3603946          DOI: 10.1136/bcr-2013-008552

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Mucormycoses.

Authors:  J Eucker; O Sezer; B Graf; K Possinger
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

2.  A black necrotic skin lesion in an immunocompromised patient. Diagnosis: cutaneous mucormycosis.

Authors:  K Adriaenssens; P G Jorens; L Meuleman; W Jeuris; J Lambert
Journal:  Arch Dermatol       Date:  2000-09

3.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

4.  Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.

Authors:  R Herbrecht; V Letscher-Bru; R A Bowden; S Kusne; E J Anaissie; J R Graybill; G A Noskin; E Andrès; L A Pietrelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

5.  Rhino-orbital and rhino-orbito-cerebral mucormycosis.

Authors:  Yoav P Talmi; Anna Goldschmied-Reouven; Mati Bakon; Iris Barshack; Michael Wolf; Zeev Horowitz; Miriam Berkowicz; Nathan Keller; Jona Kronenberg
Journal:  Otolaryngol Head Neck Surg       Date:  2002-07       Impact factor: 3.497

Review 6.  Survival factors in rhino-orbital-cerebral mucormycosis.

Authors:  R A Yohai; J D Bullock; A A Aziz; R J Markert
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

Review 7.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

  7 in total
  5 in total

1.  Rapidly progressive bilateral optic nerve and retinal infarctions due to rhinocerebral mucormycosis and pseudoephedrine use.

Authors:  Alexander E Merkler; Isha Duggal; Ulrike Kaunzner; Carolina B Maciel; Alexandra M Miller; Theresa Scognamiglio; Marc J Dinkin
Journal:  Neurol Clin Pract       Date:  2016-12

2.  Rhino-Orbital-Cerebral Mucormycosis and Orbital Exenteration.

Authors:  Matthew P Fahrenkopf; Joshua J Nelson; Mitchell Eichhorn; Julie Conway; Adam Hassan
Journal:  Eplasty       Date:  2016-11-02

3.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17

4.  Perioperative anesthetic concerns in postcovid mucormycosis patients posted for surgical intervention: An observational Study.

Authors:  Shilpi Misra; Shivani Rastogi; Deepak Malviya; Rachana Gupta; Sandeep K Yadav; Sharif Alam
Journal:  Saudi J Anaesth       Date:  2022-03-17

5.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.